Investigation of Physical Properties of a Polycaprolactone Dermal Filler when Mixed with Lidocaine and Lidocaine/Epinephrine
In esthetic treatments with dermal fillers, increasing numbers of physicians are using the technique of mixing an anesthetic agent into the dermal filler before treatment to increase the comfort of the patients. This study aimed at evaluating the effects on the physical properties of a polycaprolactone (PCL)-based dermal filler after mixing with lidocaine.
A range of 2.0% lidocaine and 2.0% lidocaine/epinephrine concentrations was mixed with the PCL dermal filler to evaluate the changes in dynamic viscosity and elasticity, extrusion force, pH, and needle jam rates. The number of passes back to forth for optimal homogeneity of lidocaine and PCL dermal filler was determined.
With 15 mixing strokes the lidocaine solution can effectively be mixed into dermal filler resulting in a homogenous blend. The viscosity, elasticity, and the extrusion force decrease with increasing lidocaine volume. The viscosity and elasticity of the dermal filler is sufficient to keep the PCL microspheres in suspension. There were no needle jams. The pH of the PCL dermal filler mixed with lidocaine solution is equivalent to that of the original dermal filler.
It is concluded that mixing of lidocaine into the PCL-based dermal filler can safely be performed without harmful changes in the physical properties of the original dermal filler.
- Middelton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomat. 2000;21:2335–46. CrossRef
- Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater. 2003;5:1–16.
- Hutmacher D, Hűrzeler MB, Schliephake H. A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications. Int J Oral Maxillofac Implants. 1996;11:667–78.
- Sihna VR, Bansal K, Kaushik R, Kumria R, et al. Poly-ε-caprolactone microspheres and nanospheres: an overview. Int J Pharm. 2004;278:1–23. CrossRef
- Turaev AS. Dependence of the biodegradability of carboxymethylcellulose on its supermolecular structure and molecular parameters. Chem Nat Comp. 1995;31:254–9. CrossRef
- Falcone SJ, Doerfler AM, Berg RA. Novel synthetic dermal fillers based on sodium carboxymethylcellulose: comparison with crosslinked hyaluronic acid-based dermal fillers. Dermatol Surg. 2007;33:S136–43. CrossRef
- Pitt CG, Chasalow FI, Hibionada DM, et al. Aliphatic polyesters: I. The degradation of poly (ε-caprolactone) in vivo. J Appl Polym Sci. 1981;26:3779–87. CrossRef
- Pitt CG. Poly (ε-caprolactone) and its copolymers. In: Chassin M, Langer R, editors. Biodegradable polymers as drug delivery systems. New York: Dekker; 1990. p. 71–119.
- Taylor MS, Daniels AU, Andriano KP, Heller J. Six biodegradable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomat. 1994;5:151–7. CrossRef
- Ma G, Song C, Sun H, Yang J, Leng X. A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs. Contracept. 2006;74:141–7. CrossRef
- Sun H, Mei L, Song C, Cui X, Wang P. The in vivo degradation, absorption and excretion of PCL-based implant. Biomat. 2006;27:1735–40. CrossRef
- Morhenn VB, Lemperle G, Gallo RL. Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells. Dermatol Surg. 2002;28:484–90. CrossRef
- Laeschke K. Biocompatibility of microparticles into soft tissue fillers. Semin Cutan Med Surg. 2004;23:214–7. CrossRef
- Busso M, Applebaum D. Hand augmentation with Radiesse (calcium hydroxylapatite). Dermatol Ther. 2007;20:385–7. CrossRef
- Hedén P, Fagrell D, Jernbeck J, et al. Injection of stabilized hyaluronic acid-based gel of non-animal origin for the correction of nasolabial folds: comparison with and without lidocaine. Dermatol Surg. 2010;36(S1):775–81.
- Levy P, De Boulle K, Raspaldo H. A split-face comparison of a new hyaluronic acid facial filler containing pre-incorporated lidocaine versus a standard hyaluronic acid facial filler in the treatment of naso-labial folds. J Cosmet Laser Ther. 2009;11:169–73. CrossRef
- Baumann L. Dermal fillers. J Cosmet Dermatol. 2004;3(4):249–50. CrossRef
- Librowski T, Pytka K, Szaleniec M. Antihistaminergic activity of carane derivatives in isolated guinea pig ileum. Pharmacol Rep. 2009;61(6):1211–5.
- Beasly KL, Weiss MA, Weiss RA. Soft tissue augmentation using a two-way connector to supplement hyaluronic acid dermal filler with 1% lidocaine hydrochloric acid with epinephrine 1:100,000: our experience and observations. Dermatol Surg. 2010;36(4):524–6. CrossRef
- Lupo MP, Swetman G, Waller W. The effect of lidocaine when mixed with large gel particle hyaluronic acid filler tolerability and longevity: a six-month trial. J Drugs Dermatol. 2010;9(9):1097–100.
- Smith L, Cockerham K. Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration? Patient Prefer Adherence. 2011;5:133–9.
- Chen S, Cheng SX, Zhuo RX. Self-assembly strategy for the preparation of polymer based nanoparticles for drug and gene delivery. Macromol Biosci. 2011;11:576–89. CrossRef
- Perale G, Casalini T, Barri V, et al. Lidocaine release form polycaprolactone threads. J Appl Polym Sci. 2010;117:3610–4.
- Paavola A, Yliruusi J, Kajimoto Y, et al. Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm Res. 1995;12:1997–2002. CrossRef
- Investigation of Physical Properties of a Polycaprolactone Dermal Filler when Mixed with Lidocaine and Lidocaine/Epinephrine
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Dermatology and Therapy
- Online Date
- September 2012
- Print ISSN
- Online ISSN
- Springer Healthcare Communications
- Additional Links
- Dermal filler
- Esthetic treatment
- Industry Sectors